Paper presented to the 3rd Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at the Hughes Metropolitan Complex, Wichita State University, April 27, 2007.Research completed at the Dept. of Physician Assistant, Dept. of Physical Therapy, College of Health Professions, and Dept. of Kinesiology, College of EducationPhysical work capacity in heart transplant recipients typically does not exceed 60% of age-predicted normal levels. It is unknown what levels might be achieved in these patients if they were involved in strenuous exercise training prior to transplantation. A 37 year-old, professionally trained male cyclist suffered an acute myocardial infarction immediately following a road race and received a heart tr...
To the Editor: We wish to report an example of a high level of physical rehabilitation attained by a...
A 32-year-old man born with double inlet left ventricle (DILV) and other significant cardiac abnorma...
Heart transplantation (HTx) not only reduces mortality of patients with end-stage heart failure (HF)...
A project presented to the Department of Physician Assistant of Wichita State University in partial ...
I would like to thank my advisor, Kenneth H. Pitetti, PhD for his guidance, patience and contributio...
Thesis (M.Ed.) -- Wichita State University, College of Education, Dept. of Human Performance Studies...
Click on the DOI link below to access the article (may not be free).It has been well documented that...
Purpose: To describe cycling performance in a well-trained male a decade after Cardiac Transplantat...
One of the most important prognostic factors in heart failure patients is physical capacity. Patient...
Results of heart transplantation as therapy for end-stage cardiac diseases are encouraging not only ...
A 26-year-old male patient who presented with symptoms of end stage cardiac failure as a result of d...
Survival and exercise performance are key targets of heart transplantation (HT). We designed this st...
AbstractObjectives. The purpose of this study was to show that the chronotropic potential of the wel...
Cardiac transplantation has been the treatment of choice for patients with terminal cardiac insuffic...
Copyright © 2012 Francisco Buendı́a-Fuentes et al. This is an open access article distributed under ...
To the Editor: We wish to report an example of a high level of physical rehabilitation attained by a...
A 32-year-old man born with double inlet left ventricle (DILV) and other significant cardiac abnorma...
Heart transplantation (HTx) not only reduces mortality of patients with end-stage heart failure (HF)...
A project presented to the Department of Physician Assistant of Wichita State University in partial ...
I would like to thank my advisor, Kenneth H. Pitetti, PhD for his guidance, patience and contributio...
Thesis (M.Ed.) -- Wichita State University, College of Education, Dept. of Human Performance Studies...
Click on the DOI link below to access the article (may not be free).It has been well documented that...
Purpose: To describe cycling performance in a well-trained male a decade after Cardiac Transplantat...
One of the most important prognostic factors in heart failure patients is physical capacity. Patient...
Results of heart transplantation as therapy for end-stage cardiac diseases are encouraging not only ...
A 26-year-old male patient who presented with symptoms of end stage cardiac failure as a result of d...
Survival and exercise performance are key targets of heart transplantation (HT). We designed this st...
AbstractObjectives. The purpose of this study was to show that the chronotropic potential of the wel...
Cardiac transplantation has been the treatment of choice for patients with terminal cardiac insuffic...
Copyright © 2012 Francisco Buendı́a-Fuentes et al. This is an open access article distributed under ...
To the Editor: We wish to report an example of a high level of physical rehabilitation attained by a...
A 32-year-old man born with double inlet left ventricle (DILV) and other significant cardiac abnorma...
Heart transplantation (HTx) not only reduces mortality of patients with end-stage heart failure (HF)...